CHRS EPS Estimates
Coherus Oncology, Inc.
$1.01
-$0.04(-3.81%)
--
Overall
--
Value
--
Tech
--
Quality
Market Cap
--
Volume
641.45K
52W Range
$0.97 - $2.62
Target Price
--
CHRS EPS estimates for Coherus Oncology, Inc.. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CHRS EPS Estimates
- EPS growth, 3-year
- +33.52%
| Fiscal year | EPS |
|---|---|
| 2025 | $1.43 |
| 2024 | $0.25 |
| 2023 | $-2.53 |
| 2022 | $-3.76 |
| 2021 | $-3.81 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CHRS | $1.01 | -3.8% | 641.45K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |